|
Factors
| |
N
|
5-year survival (%)
|
p
|
|---|
|
Age, year
|
≤65
|
210
|
53.3
|
0.003
|
|
>65
|
96
|
34.6
| |
|
Sex
|
Male
|
235
|
44.0
|
0.039
|
|
Female
|
71
|
57.8
| |
|
Histology
|
AC
|
98
|
49.7
|
0.590
|
|
SCC
|
208
|
45.7
| |
|
Surgical type
|
Transthoracic
|
186
|
47.0
|
0.701
|
|
McKeown
|
53
|
40.4
| |
|
Transabdominal
|
67
|
51.2
| |
|
Differentiation
|
Well
|
38
|
61.9
|
0.000
|
|
Moderately
|
173
|
55.1
| |
|
Poorly
|
95
|
24.9
| |
|
T stage
|
Tis/T1
|
31
|
82.2
|
0.000
|
|
T2
|
65
|
62.1
| |
|
T3
|
159
|
43.3
| |
|
T4a
|
51
|
17.1
| |
|
N stage
|
N0
|
156
|
67.5
|
0.000
|
|
N1
|
73
|
38.6
| |
|
N2
|
52
|
14.2
| |
|
N3-4
|
25
|
9.5
| |
|
TNM stage
|
0-I
|
42
|
80.5
|
0.000
|
|
II
|
118
|
66.5
| |
|
III
|
146
|
21.3
| |
|
Weight lost
|
No/Little
|
203
|
46.5
|
0.555
|
|
Middle
|
50
|
56.8
| |
|
Large
|
53
|
41.7
| |
|
Adjuvant Chemoradiation
|
Yes
|
78
|
41.7
|
0.187
|
|
No
|
228
|
48.8
| |
|
Albumin
|
<35 g/l
|
36
|
26.7
|
0.000
|
|
35–40 g/l
|
132
|
41.6
| |
|
>40 g/l
|
138
|
57.8
| |
|
Lymphocyte
|
<1.1*109
|
42
|
48.7
|
0.780
|
|
1.1–3.2*109
|
228
|
47.5
| |
|
>3.2*109
|
36
|
42.6
| |
|
NLR
|
<5
|
289
|
47.1
|
0.787
|
|
≥5
|
17
|
47.1
| |
|
REE/kg
|
<23.2
|
245
|
50.4
|
0.024
|
|
≥23.2
|
61
|
35.2
| |
|
REE
|
Low
|
154
|
40.4
|
0.010
|
|
High
|
152
|
55.3
| |
|
FBG
|
Low
|
108
|
35.0
|
0.020
|
|
High
|
198
|
51.7
| |
|
BMI
|
Low
|
81
|
36.8
|
0.046
|
|
Normal
|
186
|
49.1
| |
|
High
|
39
|
62.8
| |
- CI confidence interval, OR odds ratio
- The results were in bold, if the 95 % CI excluded 1 or p<0.05
